CURRENT IMMUNOTHERAPY OF MULTIPLE-SCLEROSIS - A REVIEW OF CLINICAL-EXPERIENCE

Several lines of evidence suggest that immunopathological factors are critically involved in the pathogenesis of multiple sclerosis. It is t herefore not surprising that a large number of immunotherapies have be en tried or proposed. At present, none of these therapies are entirely satisfactory. However, significant progress has recently been made in the design and analysis of therapeutic multiple sclerosis studies, ra ising hopes that progress will substantially accelerate.